These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 8191553

  • 21. Hypertension and the cortisol-cortisone shuttle.
    Quinkler M, Stewart PM.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2384-92. PubMed ID: 12788832
    [Abstract] [Full Text] [Related]

  • 22. 11 beta-Hydroxysteroid dehydrogenases: tissue-specific dictators of glucocorticoid action.
    Benediktsson R, Edwards CR.
    Essays Biochem; 1996 Jun; 31():23-36. PubMed ID: 9078455
    [Abstract] [Full Text] [Related]

  • 23. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G, Pascoe L, Marc JM, Caillette A, Krozowski Z, Corvol P, Fiet J.
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
    [Abstract] [Full Text] [Related]

  • 24. Apparent mineralocorticoid excess.
    Benediktsson R, Edwards CR.
    J Hum Hypertens; 1994 May; 8(5):371-5. PubMed ID: 8064785
    [Abstract] [Full Text] [Related]

  • 25. 11 beta-Hydroxysteroid dehydrogenase: a link between the dysregulation of cortisol metabolism and hypertension.
    Donovan SJ.
    Br J Biomed Sci; 1999 May; 56(3):215-25. PubMed ID: 10824333
    [Abstract] [Full Text] [Related]

  • 26. 11 beta-Hydroxysteroid dehydrogenase.
    Stewart PM.
    Baillieres Clin Endocrinol Metab; 1994 Apr; 8(2):357-78. PubMed ID: 8092977
    [No Abstract] [Full Text] [Related]

  • 27. [11 beta-hydroxysteroid-dehydrogenase: characteristics and the clinical significance of a key enzyme in cortisol metabolism].
    Kerstens MN, Dullaart RP.
    Ned Tijdschr Geneeskd; 1999 Mar 06; 143(10):509-14. PubMed ID: 10321259
    [Abstract] [Full Text] [Related]

  • 28. Cellular selectivity of aldosterone action: role of 11 beta-hydroxysteroid dehydrogenase.
    Benediktsson R, Walker BR, Edwards CR.
    Curr Opin Nephrol Hypertens; 1995 Jan 06; 4(1):41-6. PubMed ID: 7743156
    [Abstract] [Full Text] [Related]

  • 29. 11 beta-Hydroxysteroid dehydrogenase activity in hypertension and renal disease.
    Walker BR, Edwards CR.
    Adv Nephrol Necker Hosp; 1993 Jan 06; 22():329-47. PubMed ID: 8381253
    [No Abstract] [Full Text] [Related]

  • 30. Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man.
    Walker BR, Connacher AA, Webb DJ, Edwards CR.
    Clin Sci (Lond); 1992 Aug 06; 83(2):171-8. PubMed ID: 1327632
    [Abstract] [Full Text] [Related]

  • 31. The cortisol-cortisone shuttle and hypertension.
    Stewart PM, Edwards CR.
    J Steroid Biochem Mol Biol; 1991 Aug 06; 40(4-6):501-9. PubMed ID: 1958552
    [Abstract] [Full Text] [Related]

  • 32. Expression of 11 beta-OHSD along the nephron of mammals and humans.
    Kenouch S, Alfaidy N, Bonvalet JP, Farman N.
    Steroids; 1994 Feb 06; 59(2):100-4. PubMed ID: 8191536
    [Abstract] [Full Text] [Related]

  • 33. Mineralocorticoid receptors, salt, and hypertension.
    Funder JW, Krozowski Z, Myles K, Sato A, Sheppard KE, Young M.
    Recent Prog Horm Res; 1997 Feb 06; 52():247-60; discussion 261-2. PubMed ID: 9238855
    [Abstract] [Full Text] [Related]

  • 34. Apparent mineralocorticoid excess.
    Funder JW.
    Endocrinol Metab Clin North Am; 1995 Sep 06; 24(3):613-21. PubMed ID: 8575412
    [Abstract] [Full Text] [Related]

  • 35. Genetic analysis of 11 beta-hydroxysteroid dehydrogenase.
    White PC, Obeid J, Agarwal AK, Tannin GM, Nikkila H.
    Steroids; 1994 Feb 06; 59(2):111-5. PubMed ID: 8191538
    [Abstract] [Full Text] [Related]

  • 36. 11 beta-Hydroxysteroid dehydrogenases: key enzymes in determining tissue-specific glucocorticoid effects.
    Edwards CR, Benediktsson R, Lindsay RS, Seckl JR.
    Steroids; 1996 Apr 06; 61(4):263-9. PubMed ID: 8733012
    [Abstract] [Full Text] [Related]

  • 37. Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension.
    Walker BR, Stewart PM, Shackleton CH, Padfield PL, Edwards CR.
    Clin Endocrinol (Oxf); 1993 Aug 06; 39(2):221-7. PubMed ID: 8370136
    [Abstract] [Full Text] [Related]

  • 38. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
    Palermo M, Delitala G, Sorba G, Cossu M, Satta R, Tedde R, Pala A, Shackleton CH.
    J Endocrinol Invest; 2000 Aug 06; 23(7):457-62. PubMed ID: 11005270
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. 11 beta-hydroxysteroid dehydrogenase--why is it important for the nephrologist?
    Escher G, Frey BM, Frey FJ.
    Nephrol Dial Transplant; 1995 Aug 06; 10(9):1506-9. PubMed ID: 8559452
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.